期刊文献+

HPLC法测定左卡尼汀注射液的含量及有关物质 被引量:4

HPLC determination of the content and related substances of levocarnitine injection
原文传递
导出
摘要 目的:建立简便快捷的左卡尼汀注射液含量及有关物质测定方法。方法:采用AlltechBrava Amino色谱柱(250 mm×4.6 mm,5μm),柱温40℃,以0.01 mol·L^-1磷酸盐缓冲液-乙腈(25∶75)为流动相,流速1.0 mL·min^-1,检测波长205 nm。结果:左卡尼汀与各有关物质及降解产物色谱峰分离度良好,各杂质峰互不干扰。左卡尼汀、杂质A、杂质B、杂质C、杂质D质量浓度分别在436.2~2 617、3.5~87.4、2.8~56、1.79~44.8、2.54~50.8μg·mL^-1范围内线性关系良好,平均回收率(n=9)分别为100.0%、100.1%、101.6%、95.7%和102.5%,其定量限(S/N=10)分别为167.50、4.20、22.40、60.48和30.48 ng。结论:方法学验证结果表明,本法可用于左卡尼汀注射液的质量控制。 Objective: To establish an HPLC method for the determination of the content and related substances of levocarnitine injection. Methods: The AlltechBrava Amino column( 250 mm × 4. 6 mm,5 μm) was used with a mobile phase consisting of 0. 01 mol·L^-1potassium dihydrogen phosphate buffer solution and acetonitrile( 25∶ 75) at a flow rate of 1. 0 mL·min^-1. The detection wavelength was 205 nm and the column temperature was 40 ℃. The injection volume was 10 μL. Results: The related substances and degraded products were completely separated from levocarnitine. And an excellent separation was achieved for the related substances. The calibration curves for levocarnitine,impurity A,impurity B,impurity C and impurity D revealed good linearities in the range of 436. 2-2 617 μg·mL^-1,3. 5-87. 4 μg·mL^-1,2. 8-56 μg·mL^-1,1. 79-44. 8 μg·mL^-1,2. 54-50. 8 μg·mL^-1,respectively.The average recoveries( n = 9) of the above compounds were 100. 0%,100. 1%,101. 6%,95. 7% and 102. 5%,respectively. The limits of quantification( S / N = 10) of these compounds were 167. 50 ng,4. 20 ng,22. 40 ng,60. 48 ng and 30. 48 ng respectively. Conclusion: The methodological validation results indicate that the established method can be applied to quality control of levocarnitine injection.
出处 《药物分析杂志》 CAS CSCD 北大核心 2015年第2期301-305,共5页 Chinese Journal of Pharmaceutical Analysis
基金 北京中医药大学自主选题项目(2014-JYBZZ-JS-023)
关键词 氨基酸衍生物 左卡尼汀 有关物质 高效液相色谱法 amino acid derivative levocarnitine related substances HPLC
  • 相关文献

参考文献12

二级参考文献28

  • 1赵刚,凌林.左旋卡尼汀氯化钠注射液制备工艺研究[J].安徽医药,2005,9(5):331-332. 被引量:4
  • 2赵亚明,李任,王得新,沈素.高效液相色谱法检测血浆左旋肉碱方法的建立[J].中国临床神经科学,2006,14(5):528-532. 被引量:20
  • 3国家食品药品监督管理局.WS1-(X-085)-2005Z国家药品标准[S]. 被引量:2
  • 4国家食品药品监督管理局.JX20060188国家药品标准[S]. 被引量:2
  • 5United States Pharmacopoeia Convention Inc. USP 31 [ S]. 2008:2516. 被引量:1
  • 6The Quality of Medicines of the Council of Europe. EP6.0 [ S]. 2008:2257. 被引量:1
  • 7British Pharmacopoeia Commission. BP 2007 [ S ]. 2007: 1339. 被引量:1
  • 8The United States Pharmacopeial Convention. USP 24, (Vol 2 ) . Washington, D. C:United States Pharmacopeial Cony-ention Ine, 2000 : 961 -963. 被引量:1
  • 9Matsumoto K, Ichitani Y, Ogasawara N, et al. Precolumn fluores- cence derivatizafion of eamitine and aeylcarnitines with 4-( 2-amin- oethylamino) -7-nitro-2, 1,3-benzoxadiazole. J Chromatog A, 1994 ; 678 : 241 -247. 被引量:1
  • 10De W P, Deias R, Muck S, et al. High-performance liquid chromatog- raphy and capillary electrophoresis of L-and D-carnitine by precolunm diastereomerie defivatizafion. J Chromatog B, 1994; 57:67-73. 被引量:1

共引文献16

同被引文献20

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部